Forte Biosciences IncNASDAQ:FBRX
- LAST PRICE16.6800
- TODAY'S CHANGE (%)0.6000 (3.7313%)
- Bid / Lots16.5000/ 4
- Ask / Lots17.5000/ 1
- Open / Previous Close15.2200 / 16.0800
- Day Range
- 52 Week Range
- Volume124,826
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FBRX |
|---|---|---|
| 09:32 ET | 3170 | 15.21 |
| 09:33 ET | 600 | 15.45 |
| 09:35 ET | 836 | 15.56 |
| 09:37 ET | 100 | 15.8265 |
| 09:39 ET | 200 | 15.71 |
| 09:42 ET | 600 | 15.7 |
| 09:44 ET | 2200 | 15.21 |
| 09:46 ET | 800 | 15.29 |
| 09:50 ET | 677 | 15.179 |
| 09:53 ET | 145 | 15.2 |
| 09:55 ET | 710 | 15.1362 |
| 10:04 ET | 100 | 15.52 |
| 10:20 ET | 400 | 15.515 |
| 10:22 ET | 500 | 15.92 |
| 10:24 ET | 200 | 15.52 |
| 10:26 ET | 400 | 15.52 |
| 10:27 ET | 100 | 15.49 |
| 10:29 ET | 200 | 15.815 |
| 10:36 ET | 200 | 15.96 |
| 10:40 ET | 5964 | 16.3606 |
| 10:45 ET | 300 | 16.8811 |
| 10:49 ET | 200 | 16.0801 |
| 10:54 ET | 400 | 16.13 |
| 11:03 ET | 1299 | 16.11 |
| 11:09 ET | 300 | 16.12 |
| 11:23 ET | 5297 | 16.7 |
| 11:25 ET | 5300 | 16.13 |
| 11:27 ET | 300 | 16.12 |
| 11:30 ET | 100 | 16.1862 |
| 11:36 ET | 300 | 16.4 |
| 11:38 ET | 10800 | 16.25 |
| 11:39 ET | 1620 | 16.11 |
| 11:45 ET | 800 | 16.3 |
| 11:48 ET | 1900 | 16.5 |
| 11:50 ET | 550 | 16.55 |
| 11:52 ET | 6480 | 16.15 |
| 11:54 ET | 5849 | 16.05 |
| 11:59 ET | 100 | 16.05 |
| 12:06 ET | 100 | 16.05 |
| 12:15 ET | 100 | 16.05 |
| 12:26 ET | 100 | 16.05 |
| 12:32 ET | 2000 | 16.05 |
| 12:37 ET | 100 | 15.88 |
| 12:39 ET | 200 | 16 |
| 12:50 ET | 200 | 15.88 |
| 12:57 ET | 110 | 15.8887 |
| 01:02 ET | 100 | 15.88 |
| 01:11 ET | 100 | 15.88 |
| 01:15 ET | 200 | 16 |
| 01:24 ET | 100 | 15.88 |
| 01:27 ET | 110 | 15.8 |
| 01:31 ET | 253 | 15.831 |
| 01:36 ET | 100 | 15.88 |
| 01:47 ET | 100 | 15.88 |
| 01:58 ET | 100 | 15.88 |
| 02:03 ET | 100 | 16.52 |
| 02:09 ET | 680 | 15.88 |
| 02:21 ET | 100 | 15.88 |
| 02:23 ET | 295 | 15.88 |
| 02:25 ET | 1275 | 16.5 |
| 02:32 ET | 1300 | 15.7601 |
| 02:34 ET | 1300 | 16.19 |
| 02:38 ET | 1388 | 16.5 |
| 02:41 ET | 124 | 16.61 |
| 02:43 ET | 100 | 16.04 |
| 02:50 ET | 1414 | 16.8 |
| 02:54 ET | 100 | 16.15 |
| 03:01 ET | 100 | 16.05 |
| 03:10 ET | 100 | 16.05 |
| 03:12 ET | 200 | 16.07 |
| 03:15 ET | 100 | 16.43 |
| 03:26 ET | 1750 | 16.305 |
| 03:28 ET | 1105 | 17.1 |
| 03:30 ET | 350 | 17.2 |
| 03:32 ET | 300 | 16.6676 |
| 03:37 ET | 1300 | 16.78 |
| 03:39 ET | 700 | 16.78 |
| 03:42 ET | 407 | 17.25 |
| 03:44 ET | 1273 | 17.1 |
| 03:48 ET | 123 | 17.1 |
| 03:50 ET | 543 | 16.95 |
| 03:51 ET | 1921 | 17.34 |
| 03:53 ET | 717 | 16.98 |
| 03:55 ET | 3280 | 17.55 |
| 03:57 ET | 1821 | 17.64 |
| 04:00 ET | 12791 | 16.68 |
Yesterday
Forte Biosciences to Host R&D Day December 3, 2024, from 9:00AM ET on Monday Nov 25, 2024 by Dow Jones
9:00AM ET on Monday Nov 25, 2024 by Dow Jones
Nov 20, 2024
*DJ Forte Biosciences: Private Placement Announced Earlier Includes Sale of 4.93M Shrs for $5.55 Each, and Sale of 4.62M Pre-Funded Warrants for $5.55 Each, from 4:25PM ET on Wednesday Nov 20, 2024 by Dow Jones
4:25PM ET on Wednesday Nov 20, 2024 by Dow JonesDJ Forte Biosciences More Than Doubles on $53M Private Placement, from 1:08PM ET on Wednesday Nov 20, 2024 by Dow Jones
1:08PM ET on Wednesday Nov 20, 2024 by Dow JonesForte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications, from 9:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
9:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 15, 2024
DJ Forte Biosciences Is Maintained at Buy by Chardan Capital, from 5:35PM ET on Friday Nov 15, 2024 by Dow Jones
5:35PM ET on Friday Nov 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Forte Biosciences Inc | 23.4M | -0.8x | --- |
X T L Biopharmaceuticals Ltd | 23.0M | -5.7x | --- |
IN8BIO, Inc. | 23.0M | -0.4x | --- |
Acurx Pharmaceuticals Inc | 22.8M | -1.1x | --- |
Lisata Therapeutics Inc | 24.2M | -1.1x | --- |
Cocrystal Pharma Inc | 22.4M | -1.2x | --- |
Company Information
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The Company is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and T cell subsets. It owns one United States patent for administering a combination of Gram-positive and Gram-negative bacteria along with metabolites for treatment of a wide variety of skin conditions. The Company’s subsidiaries include Forte Subsidiary, Inc., Forte Biosciences Emerald Limited, and Forte Biosciences Australia Pty Ltd.
Contact Information
- Headquarters
- 3060 PEGASUS PARK DRIVE, BUILDING 6DALLAS, TX, United States 75247
- Phone
- 310-618-6994
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Paul Wagner
- Chief Financial Officer
- Antony Riley
- Independent Director
- Scott Brun
- Independent Director
- Stephen Doberstein
- Independent Director
- Barbara Finck
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $23.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 1.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.63 |
EPS | $-20.00 |
Book Value | $24.30 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
